Atrium Biotechnologies

Atrium Innovations is a global leader in the development, manufacturing, and commercialization of science-based nutritional health products. The company's extensive portfolio includes premium brands such as Garden of Life, Pure Encapsulations, and Douglas Laboratories, which are distributed through both professional and consumer retail channels. Originally founded as Atrium Biotechnologies, the firm transitioned its focus toward the nutraceutical industry and was eventually acquired by Nestlé Health Science in 2017 for $2.3 billion. Today, it operates as a key pillar of Nestlé's health and wellness strategy, providing high-quality vitamins, minerals, and dietary supplements backed by clinical research. The company maintains a strong international presence with a focus on evidence-based nutrition and high manufacturing standards.